Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. In particular, her work has focused on the intersection of substance use and HIV-related sex and drug risk behaviors from both the consumer and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.
In two decades at UW, Dr. Hartzler’s principal focus has been on the dissemination and implementation of empirically-supported health services for persons with substance use disorders. To date, this includes local, regional, national, and international collaborations, encompassing federally-funded work with diverse community-based settings (i.e., addiction care, mental health, primary and specialty medical care, criminal justice, HIV care, schools, faith-based organizations), including those affiliated with the NIDA Clinical Trials Network. As director of the UW Center for Advancing Addiction Health Services (CAAHS), he oversees a broad portfolio, including: 1) the SAMHSA-funded Northwest Addiction Technology Transfer Center (Northwest ATTC), which provides universal, targeted, and intensive technical assistance to the addiction workforce in Alaska, Idaho, Oregon, and Washington 2) regional contribution to SAMHSA’s national Opioid Response Network (ORN), 3) a host of externally-sponsored implementation projects with single-state authorities as well as other organizations, and 4) contribution to NIH-funded and intramural health services research. In professional endeavors that span a science-to-service continuum, Dr. Hartzler seeks to promote adoption and implementation of useful treatment and recovery practices in community settings where they may benefit persons with substance use disorders.
Dr. Banta-Green studies substance use involving opioids and stimulants and interventions to support recovery and reduce substance-related harms. He is particularly interested in developing interventions that are accessible to all people, including those who are most marginalized, such as those who are unhoused, utilizing services syringe service programs, and/or in the criminal legal system. He provides technical assistance and evaluation services for public health and safety interventions including the website http://stopoverdose.org, and information for the general public and professionals about effective treatments at http://learnabouttreatment.org. As an epidemiologist he develops innovative approaches to measuring the use and impacts of substances as well as service utilization. His health services research involves clinical trials, implementation research, and secondary data analyses. He serves on local, state, and federal workgroups and committees related to epidemiology, policy, and interventions for illicit substance-related problems. He is a member of the U.S. Health and Human Service’s Interdepartmental Substance Use Disorders Coordinating Committee.
Anthony is a Research Associate Professor, providing clinical trial and regulatory expertise in the treatment and prevention of substance use disorder, in particular opioid use disorder. He has directed numerous clinical trials and program evaluations in both community treatment and emergency department settings. Dr. Floyd has a secondary focus in firearm injury prevention research, which examines many of the same underlying public health concerns as substance use disorder. In addition, Anthony leads a team from Washington in a multi-site, multi-state study, examining the effectiveness of an opioid safety and education training program aimed at pharmacists in community-based settings.
I am a perinatal and addiction psychiatrist and Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences. My main area of interest and expertise is substance use disorders in the perinatal period as well as women’s mental health more generally. I am also passionate about doing my part to address inequities in healthcare.
I am interested in assessing risky alcohol and substance use and related consequences in young adults, with a specific focus on impaired driving-related behaviors. My work has mostly utilized a behavioral decision-making approach to understand factors that influence young adults’ decisions to engage in risky behaviors. I am also interested in developing and adapting prevention and intervention programs to reduce alcohol and substance use and consequences.
I am a developmental psychologist with additional training and expertise in quantitative methods. I am an associate professor in the UW Department of Psychiatry and Behavioral Sciences, a core member of the Center for the Study of Health and Risk Behaviors (CSHRB), faculty affiliate of the Center for Studies in Demography and Ecology (CSDE), and adjunct faculty at the UW School of Social Work. My main collaborations at UW involve colleagues from CSHRB but I also maintain strong research collaborations with my colleagues from the Social Development Research Group (SDRG), School of Social Work, and other departments. In addition to research, I occasionally teach graduate-level classes on research methods and evaluation in social welfare (SOCW505, SOCW506, SOCW507) and research and theory (SOCWL599) at the School of Social Work. I am also actively involved in mentoring graduate students and postdoctoral fellows.
Personal Statement
I am a Professor of Psychiatry and Director of the Addictions Division in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle, Washington. I am also the clinical director of addictions treatment services at Harborview Medical Center, and work in the psychiatric rehabilitation and recovery services.
I am board-certified in Psychiatry by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry, and the American Board of Addiction Medicine. A Distinguished Fellow of the American Psychiatric Association and a Fellow of the American Society of Addiction Medicine, I am on the editorial board and a reviewer for several scientific journals and holds a number of research grants from the National Institute of Health.
